Nurses safely and effectively prescribe antiretroviral drugs in pilot programOctober 13, 2009Press release from PLoS Medicine Given sufficient training and support, nurses can safely and effectively prescribe antiretroviral therapy (ART) to patients with HIV, according to a Rwandan study published in this week's PLoS Medicine. As in many other African countries, Rwanda has a shortage of doctors, which implies that many patients with HIV aren't receiving the treatment they need. To tackle this crisis, the World Health Organization recommends "task shifting"-whereby the task of prescribing ART is shifted from doctors to nurses so that more patients can be treated. In September 2005, Rwanda launched a pilot program of task shifting. One nurse in each of three rural primary health centers was trained to examine patients with HIV and prescribe ART in simple cases (complex cases were referred to a doctor). Nurses had to complete at least 50 consultations with patients eligible for ART under the observation of a doctor before being allowed to treat patients independently. The new study, by Fabienne Shumbusho (Family Health International, Kigali, Rwanda) and colleagues, evaluates the success and safety of the program. Shumbusho and colleagues reviewed the medical records of 1,076 patients enrolled in the program between September 2005 and March 2008. They examined whether the nurses had followed national guidelines on ART prescription and monitored the patients correctly. They also looked at patients' health outcomes, such as their death rate, changes in body weight and CD4 cell count (a marker of how healthy the patient's immune system was), and whether patients maintained contact with caregivers. The researchers found that by March 2008, 451 patients had been eligible for ART, of whom 435 received treatment. None of the patients were prescribed ART when they should not have been. Only one prescription did not follow national guidelines. At every visit, nurses were supposed to assess whether patients were taking their drugs (known as "adherence") and to monitor side effects. They did this most of the time (in 89% of clinic visits, nurses assessed adherence, and in 85% of visits they assessed side effects). By March 2008, 390 (90%) patients were alive on ART, 29 (7%) had died, only one (under 1%) was lost to follow-up, and none had stopped treatment. Most patients gained weight in the first six months and their CD4 cell counts increased. Outcomes, including death rate, were similar to those from the doctor-led Rwandan national ART program and other African national doctor-led programs. The study, say the authors, "demonstrates the feasibility and suggests effectiveness of nurse-centered task shifting for decentralized ART services without compromising the quality of care." But there are also several limitations to the study, which the authors discuss in their paper. For example, the authors say that they did not directly compare outcomes from this nurse-centered model of care with those from traditional physician-centered models. This makes it difficult to ascertain if patients' outcomes were as a result of the nurses' role or due to doctors' intensive supervision. Public Library of Science |
|||||||||||||||||||||
| Related Antiretroviral Therapy Current Events and Antiretroviral Therapy News Articles Many pregnant women avoid HIV screening in Africa 'Prevention is the best cure' is a common expression, but what happens if preventative measures are not used? A large proportion of pregnant Ugandan women are going out of their way not to be HIV tested, increasing the risk of mother-to-child transmission. Taking medicine for HIV proves hard to swallow for many people Highly active antiretroviral therapy has increased the longevity and quality of life for people living with human immunodeficiency virus. But it requires strict adherence in taking the medicine, something that is extremely difficult for many individuals to do. Feelings of stigmatization may discourage HIV patients from proper care The feeling of stigmatization that people living with HIV often experience doesn't only exact a psychological toll -new UCLA research suggests it can also lead to quantifiably negative health outcomes. Maternal HIV-1 treatment protects against transmission to newborns Mothers receiving highly active antiretroviral therapy (HAART) to treat HIV-1 infection are less likely than untreated mothers to transmit the virus to their newborns through breastfeeding. Research shows treating HIV-AIDS with interleukin-2 is ineffective An international research team has demonstrated that treating HIV-AIDS with interleukin-2 (IL-2) is ineffective. As a result, the researchers recommend that clinical trials on this compound be stopped. Study finds nontuberculous mycobacteria lung disease on the rise in the United States Nontuberculous mycobacteria (NTM) are environmental organisms found in both water and soil that can cause severe pulmonary (lung) disease in humans. Pulmonary NTM is on the rise in the United States, according to a large study of people hospitalized with the condition. HIV vaccine regimen demonstrates modest preventive effect in Thailand clinical study In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand. Updated Guidelines Highlight Primary Care Needs of Those Living With HIV With HIV patients living longer thanks to advances in treatment, the primary care needs of those living with HIV have never been more important. Protein excreted in urine may be help in diagnosing kidney disease caused by HIV New data collected at Columbia University Medical Center and by the Mount Sinai School of Medicine are helping researchers understand the extent to which a certain protein - NGAL - can play a significant role in marking chronic kidney disease resulting from HIV while at the same time distinguishing nephropathy from more common causes such as diabetes and hypertension. Focusing HIV treatment helps control concurrent hepatitis B infection Prolonged use of highly active antiretroviral therapy (HAART) to treat people infected with both HIV and hepatitis B (HBV) helps to better control the hepatitis B infection and could delay or prevent liver complications. More Antiretroviral Therapy Current Events and Antiretroviral Therapy News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||